The potential of pamrevlumab in diseases with underlying mechanisms of fibrotic processes and its prospects in ophthalmology
Introduction: Pamrevlumab, a monoclonal antibody targeting CTGF, is considered a potential therapy for eye diseases involving fibrosis. The aim of this study was to explore its potential in treating eye diseases. Methods: A systematic review was conducted following PRISMA guidelines, searc...
Saved in:
Main Authors: | Lely Retno Wulandari, Edwin Damar Prabowo, Happy Kurnia Permata Sari, Hidayat Sujuti, Sri Winarsih |
---|---|
Format: | Article |
Language: | English |
Published: |
Pensoft Publishers
2025-06-01
|
Series: | Pharmacia |
Online Access: | https://pharmacia.pensoft.net/article/144964/download/pdf/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Knowledge-Based Discovery of Anti-Fibrotic and Pro-Fibrotic Activities from Chinese Materia Medica
by: Xu, Qihe, et al.
Published: (2012) -
Effects of Doxorubicin on Fibrotic Remodeling in the Heart
by: Sukriti Bagchi, et al.
Published: (2025-06-01) -
Differential Diagnosis of Fibrotic Hypersensitivity Pneumonitis with Its Non-Fibrotic Phenotype and Usual Interstitial Pneumonia During High-Resolution Computed Tomography
by: I. E. Tuyrin, et al.
Published: (2023-11-01) -
The Fibrotic Response to Implanted Biomaterials: Implications for Tissue Engineering
by: Rolfe, Barbara, et al.
Published: (2011) -
Enhancing Indonesian nurses' competencies through electronic continuing professional development: An action research study
by: Novita Kurnia Sari, et al.
Published: (2025-06-01)